Mit Freunden aus Indien hat Gunjan Bhardwaj in Deutschland Innoplexus aufgebaut – eine ausgeklügelte Suchmaschine für die Pharmabranche, die Profiwissen aus dem Internet und Datenbanken aufspürt und aufbereitet. Gunjan Bhardwaj (35)...
Read More
Successful clinical trials occur at a ratio of 1 in 10, costing around $2-$3 billion, with drugs taking 10–12 years to be approved. High costs, 90% failure rate, and the lengthy...
Read More
Frankfurt, Germany – Innoplexus AG, a leading global artificial intelligence (AI) company with over 80 patent applications in AI, machine learning and blockchain technologies, has received series C funding in...
Read More
Frankfurt, Germany – On March 21st, 2019, Biogen’s stock declined sharply, showing a decrease of 29%, resulting in losses to the tune of $18Bn for investors after the company ended...
Read More
Before Biogen Inc.’s experimental Alzheimer’s disease drug failed in a trial last month, analysts surveyed by Bloomberg estimated annual sales of about $3.7 billion by 2023. A German artificial-intelligence firm...
Read More
It can be hard to stay healthy in a convention center filled with thousands of people — unless, of course, you’re at the GPU Technology Conference, where healthcare players big...
Read More
The Indian pharmaceutical industry has emerged as a significant contributor to the global pharmaceutical industry. As per the report by the Federation of Indian Chamber of Commerce and Industries (FICCI),...
Read More
The evolution of artificial intelligence (AI) has taken the healthcare sector by a storm promising enhanced data analytics for effective decision making. However, most of the AI tools have failed...
Read More
AI enabled healthcare is swiftly becoming today’s reality, fueled by innovative startups in the field. These startups are leveraging GPUs to develop AI applications that can analyze large amounts of...
Read More
Digitalization is becoming a source of hope: new analyses, networking, and larger amounts of data could give a boost to drug development. "Data, data everywhere, but no drugs," lamented Jerry Karabelas,...
Read More
